Who made the mRNA vaccine? Measuring division of labor in therapeutic innovation.

Who made the mRNA vaccine? Measuring division of labor in therapeutic innovation.

Accepted version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/376183

Repository DOI

https://doi.org/10.17863/CAM.113517

Files

Primary Accepted version (1.17 MB)

Type

Authors

Ho, Martin

https://orcid.org/0000-0003-2192-6198

Price, Henry CW

Evans, Tim S

https://orcid.org/0000-0003-3501-6486

O'Sullivan, Eoin

Abstract

To accelerate future vaccine development, understanding the longer-term funding dynamics behind recent successes such as the USA’s Operation Warp Speed and the UK’s Vaccine Taskforce is imperative.

Keywords

32 Biomedical and Clinical Sciences, 3204 Immunology, Vaccine Related, Immunization, Prevention, Biotechnology, 3.4 Vaccines, 3 Good Health and Well Being

Journal Title

Nat Biotechnol

Journal ISSN

1087-0156
1546-1696

Volume Title

42

Publisher

Springer Nature

Publisher DOI

https://doi.org/10.1038/s41587-024-02441-7

Rights and licensing

Attribution 4.0 International (CC BY 4.0)

Except where otherwised noted, this item's license is described as Attribution 4.0 International (CC BY 4.0)

Sponsorship

Gatsby Charitable Foundation (GAT3816)

Collections

University of Cambridge Research Outputs (Articles and Conferences)